LEADING THE WAY
IGY Life Sciences & Immune Technology Inc. is a privately held biotechnology company specializing in the
development, manufacturing and licensing of immunoglobulin (IgY), for use in biologic
treatments, nutraceuticals and animal health solutions. The company was formed in 2009 to commercialize a superior proprietary process for the extraction of avian immunoglobulin from chicken egg yolks. Our mission is to actualize the long promise of IgY Technology. We are currently in development of multiple pre-clinical candidates that address a wide range of therapeutic areas including Anti-Coronavirus Antibodies, African Swine Flu, and Rotavirus.